182 related articles for article (PubMed ID: 10394036)
1. Cannabis psychosis and acute schizophrenia. a case-control study from India.
Basu D; Malhotra A; Bhagat A; Varma VK
Eur Addict Res; 1999 Jun; 5(2):71-3. PubMed ID: 10394036
[TBL] [Abstract][Full Text] [Related]
2. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
3. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
4. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
[TBL] [Abstract][Full Text] [Related]
5. Variable individual sensitivity to cannabis in patients with schizophrenia.
Goldberger C; Dervaux A; Gourion D; Bourdel MC; Lôo H; Laqueille X; Krebs MO
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1145-54. PubMed ID: 20529414
[TBL] [Abstract][Full Text] [Related]
6. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
[TBL] [Abstract][Full Text] [Related]
7. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
Hides L; Dawe S; Kavanagh DJ; Young RM
Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
[TBL] [Abstract][Full Text] [Related]
8. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
Hambrecht M; Häfner H
Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
[TBL] [Abstract][Full Text] [Related]
9. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
[TBL] [Abstract][Full Text] [Related]
10. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD).
Hollis C; Groom MJ; Das D; Calton T; Bates AT; Andrews HK; Jackson GM; Liddle PF
Schizophr Res; 2008 Oct; 105(1-3):216-23. PubMed ID: 18768298
[TBL] [Abstract][Full Text] [Related]
11. Thought disorder. A function of schizophrenia, mania, or psychosis?
Marengo J; Harrow M
J Nerv Ment Dis; 1985 Jan; 173(1):35-41. PubMed ID: 3965610
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
Rodríguez-Sánchez JM; Ayesa-Arriola R; Mata I; Moreno-Calle T; Perez-Iglesias R; González-Blanch C; Periañez JA; Vazquez-Barquero JL; Crespo-Facorro B
Schizophr Res; 2010 Dec; 124(1-3):142-51. PubMed ID: 20826079
[TBL] [Abstract][Full Text] [Related]
13. [Duration of untreated psychosis in first-episode schizophrenia: clinical and cognitive correlates].
Galińska B; Szulc A; Czernikiewicz A
Psychiatr Pol; 2005; 39(5):859-68. PubMed ID: 16358587
[TBL] [Abstract][Full Text] [Related]
14. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.
Foti DJ; Kotov R; Guey LT; Bromet EJ
Am J Psychiatry; 2010 Aug; 167(8):987-93. PubMed ID: 20478874
[TBL] [Abstract][Full Text] [Related]
16. Duration of psychosis and outcome in first-episode schizophrenia.
Loebel AD; Lieberman JA; Alvir JM; Mayerhoff DI; Geisler SH; Szymanski SR
Am J Psychiatry; 1992 Sep; 149(9):1183-8. PubMed ID: 1503130
[TBL] [Abstract][Full Text] [Related]
17. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
[TBL] [Abstract][Full Text] [Related]
18. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.
Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
Br J Psychiatry; 2005 Dec; 187():510-5. PubMed ID: 16319402
[TBL] [Abstract][Full Text] [Related]
19. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
[TBL] [Abstract][Full Text] [Related]
20. Early course of schizophrenia in a representative Dutch incidence cohort.
Selten JP; Veen ND; Hoek HW; Laan W; Schols D; van der Tweel I; Feller W; Kahn RS
Schizophr Res; 2007 Dec; 97(1-3):79-87. PubMed ID: 17683911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
